| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.65B | 72.19B | 73.04B | 72.87B | 68.14B | 64.29B |
| Gross Profit | 14.23B | 14.71B | 14.16B | 15.20B | 10.26B | 11.07B |
| EBITDA | 6.61B | 7.15B | 6.42B | 18.14B | 320.00M | -4.03B |
| Net Income | 3.04B | 3.27B | 2.77B | 12.26B | -3.01B | -9.65B |
Balance Sheet | ||||||
| Total Assets | 95.14B | 97.50B | 94.85B | 94.14B | 87.60B | 97.37B |
| Cash, Cash Equivalents and Short-Term Investments | 10.12B | 11.15B | 10.79B | 10.99B | 7.65B | 11.13B |
| Total Debt | 24.13B | 22.15B | 24.66B | 23.89B | 33.54B | 35.56B |
| Total Liabilities | 41.43B | 41.12B | 40.47B | 42.55B | 50.11B | 57.15B |
| Stockholders Equity | 54.11B | 56.78B | 54.78B | 51.43B | 37.35B | 39.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.33B | 939.00M | 3.19B | -145.00M | 3.76B |
| Operating Cash Flow | 0.00 | 8.16B | 6.65B | 5.66B | 1.62B | 5.58B |
| Investing Cash Flow | 0.00 | -3.43B | -5.57B | 7.72B | -2.93B | -1.49B |
| Financing Cash Flow | 0.00 | -4.38B | -1.47B | -10.12B | -2.21B | -3.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥142.96B | 6.66 | 10.46% | 2.35% | 2.55% | 72.25% | |
76 Outperform | ¥584.59B | 9.78 | 6.90% | 2.71% | 4.41% | 176.65% | |
74 Outperform | ¥78.43B | 21.16 | ― | 6.64% | 2.45% | 1.87% | |
68 Neutral | ¥12.04B | -671.21 | ― | 1.95% | 6.28% | -15.61% | |
65 Neutral | ¥26.23B | 8.78 | ― | 6.14% | -1.56% | 17.80% | |
63 Neutral | ¥97.18B | 12.05 | 7.53% | 3.01% | 5.17% | 20.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |